5 Takeaways from the ACR’s Gout Clinical Quality Measures
Reduced Serum Uric Acid Levels May Protect Against Renal Function Decline
Pathophysiology of Gouty Tophi
Study Finds Newer Gout Drug Poses Risk to Heart Patients
Patients with Gout May Be More Likely to Develop Osteoporosis
European Commission Approves Subcutaneous Belimumab for SLE; FDA Safety Alert for Febuxostat
Year in Review: Expert Covers Year’s Key Clinical Findings
Hyperuricemia Doesn’t Always Indicate Gout in Rheumatic Disease
FDA Approves Lesinurad + Allopurinol
- 1
- 2
- 3
- …
- 10
- Next Page »